LOCUS       NP_009297               1148 aa            linear   PRI 20-DEC-2003
DEFINITION  v-abl Abelson murine leukemia viral oncogene homolog 1 isoform b;  
            Abelson murine leukemia viral (v-abl) oncogene homolog 1;          
            proto-oncogene tyrosine-protein kinase ABL1 [Homo sapiens].        
ACCESSION   NP_009297                                                          
VERSION     NP_009297.1  GI:6382058                                            
DBSOURCE    REFSEQ: accession NM_007313.1                                      
KEYWORDS    .                                                                  
SOURCE      Homo sapiens (human)                                               
  ORGANISM  Homo sapiens                                                       
            Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;  
            Mammalia; Eutheria; Primates; Catarrhini; Hominidae; Homo.         
REFERENCE   1  (residues 1 to 1148)                                            
  AUTHORS   Sacha,T., Hochhaus,A., Hanfstein,B., Muller,M.C., Rudzki,Z.,       
            Czopek,J., Wolska-Smolen,T., Czekalska,S., Salamanchuk,Z.,         
            Jakobczyk,M. and Skotnicki,A.B.                                    
  TITLE     ABL-kinase domain point mutation as a cause of imatinib (STI571)   
            resistance in CML patient who progress to myeloid blast crisis     
  JOURNAL   Leuk. Res. 27 (12), 1163-1166 (2003)                               
   PUBMED   12921956                                                           
  REMARK    GeneRIF: ABL-kinase domain point mutation as a cause of imatinib   
            resistance in CML patient who progress to myeloid blast crisis     
REFERENCE   2  (residues 1 to 1148)                                            
  AUTHORS   Puccetti,E., Beissert,T., Guller,S., Li,J.E., Hoelzer,D.,          
            Ottmann,O.G. and Ruthardt,M.                                       
  TITLE     Leukemia-associated translocation products able to activate RAS    
            modify PML and render cells sensitive to arsenic-induced apoptosis 
  JOURNAL   Oncogene 22 (44), 6900-6908 (2003)                                 
   PUBMED   14534537                                                           
  REMARK    GeneRIF: ABL fuses with BCR to form a fusion protein.              
REFERENCE   3  (residues 1 to 1148)                                            
  AUTHORS   Zhou,H.X.                                                          
  TITLE     How often does the myristoylated N-terminal latch of c-Abl come    
            off?                                                               
  JOURNAL   FEBS Lett. 552 (2-3), 160-162 (2003)                               
   PUBMED   14527680                                                           
  REMARK    GeneRIF: the equilibrium fraction of c-Abl in which the            
            myristoylated N-terminal is unlatched is approximately 0.5%        
REFERENCE   4  (residues 1 to 1148)                                            
  AUTHORS   Cao,C., Leng,Y., Liu,X., Yi,Y., Li,P. and Kufe,D.                  
  TITLE     Catalase is regulated by ubiquitination and proteosomal            
            degradation. Role of the c-Abl and Arg tyrosine kinases            
  JOURNAL   Biochemistry 42 (35), 10348-10353 (2003)                           
   PUBMED   12950161                                                           
  REMARK    GeneRIF: findings indicate that, in addition to stimulating        
            catalase activity, c-Abl and Arg promote catalase degradation in   
            the oxidative stress response                                      
REFERENCE   5  (residues 1 to 1148)                                            
  AUTHORS   Cheng,W.H., von Kobbe,C., Opresko,P.L., Fields,K.M., Ren,J.,       
            Kufe,D. and Bohr,V.A.                                              
  TITLE     Werner syndrome protein phosphorylation by abl tyrosine kinase     
            regulates its activity and distribution                            
  JOURNAL   Mol. Cell. Biol. 23 (18), 6385-6395 (2003)                         
   PUBMED   12944467                                                           
  REMARK    GeneRIF: we have identified a direct binding between WRN and c-Abl 
            in vitro via the N-terminal and central regions of WRN and the Src 
            homology domain 3 of c-Abl. These findings suggest a novel         
            signaling pathway                                                  
REFERENCE   6  (residues 1 to 1148)                                            
  AUTHORS   Ben-Yehoyada,M., Ben-Dor,I. and Shaul,Y.                           
  TITLE     c-Abl tyrosine kinase selectively regulates p73 nuclear matrix     
            association                                                        
  JOURNAL   J. Biol. Chem. 278 (36), 34475-34482 (2003)                        
   PUBMED   12824179                                                           
  REMARK    GeneRIF: c-Abl tyrosine kinase selectively regulates p73 nuclear   
            matrix association                                                 
REFERENCE   7  (residues 1 to 1148)                                            
  AUTHORS   Truong,T., Sun,G., Doorly,M., Wang,J.Y. and Schwartz,M.A.          
  TITLE     Modulation of DNA damage-induced apoptosis by cell adhesion is     
            independently mediated by p53 and c-Abl                            
  JOURNAL   Proc. Natl. Acad. Sci. U.S.A. 100 (18), 10281-10286 (2003)         
   PUBMED   12928501                                                           
  REMARK    GeneRIF: differential utilization of the p53 and c-Abl/p73 pathways
            by different tumor cell line.                                      
REFERENCE   8  (residues 1 to 1148)                                            
  AUTHORS   Jaiswal,S., Traver,D., Miyamoto,T., Akashi,K., Lagasse,E. and      
            Weissman,I.L.                                                      
  TITLE     Expression of BCR/ABL and BCL-2 in myeloid progenitors leads to    
            myeloid leukemias                                                  
  JOURNAL   Proc. Natl. Acad. Sci. U.S.A. 100 (17), 10002-10007 (2003)         
   PUBMED   12890867                                                           
  REMARK    GeneRIF: Expression of BCR/ABL and BCL-2 in myeloid progenitors    
            leads to myeloid leukemias.                                        
REFERENCE   9  (residues 1 to 1148)                                            
  AUTHORS   Cao,C., Leng,Y. and Kufe,D.                                        
  TITLE     Catalase activity is regulated by c-Abl and Arg in the oxidative   
            stress response                                                    
  JOURNAL   J. Biol. Chem. 278 (32), 29667-29675 (2003)                        
   PUBMED   12777400                                                           
  REMARK    GeneRIF: c-Abl and Arg regulate catalase and that this signaling   
            pathway is of importance to apoptosis in the oxidative stress      
            response                                                           
REFERENCE   10 (residues 1 to 1148)                                            
  AUTHORS   Master,Z., Tran,J., Bishnoi,A., Chen,S.H., Ebos,J.M., Van Slyke,P.,
            Kerbel,R.S. and Dumont,D.J.                                        
  TITLE     Dok-R binds c-Abl and regulates Abl kinase activity and mediates   
            cytoskeletal reorganization                                        
  JOURNAL   J. Biol. Chem. 278 (32), 30170-30179 (2003)                        
   PUBMED   12777393                                                           
  REMARK    GeneRIF: Dok-R and c-Abl interact in both a constitutive and       
            inducible fashion and Dok-R influences the intracellular kinase and
            biological activity of c-Abl                                       
REFERENCE   11 (residues 1 to 1148)                                            
  AUTHORS   Chien,W., Tidow,N., Williamson,E.A., Shih,L.Y., Krug,U.,           
            Kettenbach,A., Fermin,A.C., Roifman,C.M. and Koeffler,H.P.         
  TITLE     Characterization of a myeloid tyrosine phosphatase, Lyp, and its   
            role in the Bcr-Abl signal transduction pathway                    
  JOURNAL   J. Biol. Chem. 278 (30), 27413-27420 (2003)                        
   PUBMED   12764153                                                           
  REMARK    GeneRIF: BCR-ABL is inhibited by lyp tyrosine phosphatase          
REFERENCE   12 (residues 1 to 1148)                                            
  AUTHORS   Branford,S., Rudzki,Z., Walsh,S., Parkinson,I., Grigg,A., Szer,J., 
            Taylor,K., Herrmann,R., Seymour,J.F., Arthur,C., Joske,D., Lynch,K.
            and Hughes,T.                                                      
  TITLE     Detection of BCR-ABL mutations in patients with CML treated with   
            imatinib is virtually always accompanied by clinical resistance,   
            and mutations in the ATP phosphate-binding loop (P-loop) are       
            associated with a poor prognosis                                   
  JOURNAL   Blood 102 (1), 276-283 (2003)                                      
   PUBMED   12623848                                                           
  REMARK    GeneRIF: detection of kinase domain mutations was almost always    
            associated with imatinib resistance, and patients with mutations in
            the P-loop had a particularly poor prognosis                       
REFERENCE   13 (residues 1 to 1148)                                            
  AUTHORS   Tsai,K.K. and Yuan,Z.M.                                            
  TITLE     c-Abl stabilizes p73 by a phosphorylation-augmented interaction    
  JOURNAL   Cancer Res. 63 (12), 3418-3424 (2003)                              
   PUBMED   12810679                                                           
  REMARK    GeneRIF: c-Abl increases the cellular p73 abundance through        
            posttranslational regulation. Kinase activity is essential for     
            c-Abl to up-regulate p73. c-Abl contributes to either pro- or      
            antiapoptotic process depending on the expression profile of p73   
            isoforms.                                                          
REFERENCE   14 (residues 1 to 1148)                                            
  AUTHORS   Gargallo,P.M., Cuello,M.T., Aranguren,P.N. and Larripa,I.B.        
  TITLE     Amplification of the BCR/ABL fusion gene clustered on a masked     
            Philadelphia chromosome in a patient with myeloblastic crisis of   
            chronic myelocytic leukemia                                        
  JOURNAL   Cancer Genet. Cytogenet. 143 (2), 140-144 (2003)                   
   PUBMED   12781448                                                           
  REMARK    GeneRIF: BCR/ABL amplification may play a role as a novel mechanism
            in the progression to an aggressive blast transformation in some   
            cases of Philadelphia chromosome-positive chronic myelocytic       
            leukemia                                                           
REFERENCE   15 (residues 1 to 1148)                                            
  AUTHORS   Tani,K., Sato,S., Sukezane,T., Kojima,H., Hirose,H., Hanafusa,H.   
            and Shishido,T.                                                    
  TITLE     Abl interactor 1 promotes tyrosine 296 phosphorylation of mammalian
            enabled (Mena) by c-Abl kinase                                     
  JOURNAL   J. Biol. Chem. 278 (24), 21685-21692 (2003)                        
   PUBMED   12672821                                                           
  REMARK    GeneRIF: c-Abl-mediated phosphorylation of Mena is regulated by    
            Abi-1                                                              
REFERENCE   16 (residues 1 to 1148)                                            
  AUTHORS   Barila,D., Rufini,A., Condo,I., Ventura,N., Dorey,K.,              
            Superti-Furga,G. and Testi,R.                                      
  TITLE     Caspase-dependent cleavage of c-Abl contributes to apoptosis       
  JOURNAL   Mol. Cell. Biol. 23 (8), 2790-2799 (2003)                          
   PUBMED   12665579                                                           
  REMARK    GeneRIF: mechanism by which caspases can recruit c-Abl to the      
            nuclear compartment and to the mammalian apoptotic program         
REFERENCE   17 (residues 1 to 1148)                                            
  AUTHORS   Yuan,S.S., Chang,H.L. and Lee,E.Y.                                 
  TITLE     Ionizing radiation-induced Rad51 nuclear focus formation is cell   
            cycle-regulated and defective in both ATM(-/-) and c-Abl(-/-) cells
  JOURNAL   Mutat. Res. 525 (1-2), 85-92 (2003)                                
   PUBMED   12650908                                                           
  REMARK    GeneRIF: In conclusion, effective and prompt IR-induced Rad51 focus
            formation is cell cycle-regulated and requires both ATM and c-Abl. 
REFERENCE   18 (residues 1 to 1148)                                            
  AUTHORS   Hantschel,O., Nagar,B., Guettler,S., Kretzschmar,J., Dorey,K.,     
            Kuriyan,J. and Superti-Furga,G.                                    
  TITLE     A myristoyl/phosphotyrosine switch regulates c-Abl                 
  JOURNAL   Cell 112 (6), 845-857 (2003)                                       
   PUBMED   12654250                                                           
  REMARK    GeneRIF: This gene is regulated by a myristoyl/phosphotyrosine     
            switch.                                                            
REFERENCE   19 (residues 1 to 1148)                                            
  AUTHORS   Traina,F., Carvalheira,J.B., Saad,M.J., Costa,F.F. and Saad,S.T.   
  TITLE     BCR-ABL binds to IRS-1 and IRS-1 phosphorylation is inhibited by   
            imatinib in K562 cells                                             
  JOURNAL   FEBS Lett. 535 (1-3), 17-22 (2003)                                 
   PUBMED   12560071                                                           
  REMARK    GeneRIF: concluded that the IRS-1 protein is involved in the       
            signalling pathway of the BCR-ABL tyrosine kinase                  
REFERENCE   20 (residues 1 to 1148)                                            
  AUTHORS   Strife,A., Wisniewski,D., Liu,C., Lambek,C.L., Darzynkiewicz,Z.,   
            Silver,R.T. and Clarkson,B.                                        
  TITLE     Direct evidence that Bcr-Abl tyrosine kinase activity disrupts     
            normal synergistic interactions between Kit ligand and cytokines in
            primary primitive progenitor cells                                 
  JOURNAL   Mol. Cancer Res. 1 (3), 176-185 (2003)                             
   PUBMED   12556557                                                           
  REMARK    GeneRIF: constitutively activated Bcr-Abl kinase pathways in       
            primitive CML progenitors cooperate with growth factors producing a
            growth response and disrupt the normally required synergistic      
            interactions between kit ligand and other cytokines to achieve     
            activation                                                         
REFERENCE   21 (residues 1 to 1148)                                            
  AUTHORS   Aboura,A., Labrune,P., Perreaux,F., Poncet,V., Brisset,S.,         
            Foix-L'Helias,L. and Tachdjian,G.                                  
  TITLE     Deletion in the ABL gene resulting from a meiotic recombination of 
            a maternal (3;22;9)(q22;q12;q34.1) translocation                   
  JOURNAL   J. Med. Genet. 40 (1), E6 (2003)                                   
   PUBMED   12525554                                                           
  REMARK    GeneRIF: An inherited, apparently balanced translocation involving 
            chromosomes 3(q22), 22(q12), and 9(q34.1, resulting from meiotic   
            recombination, leads to deletion in the ABL gene in a child with   
            axial hypotonia and dysmorphism. )                                 
REFERENCE   22 (residues 1 to 1148)                                            
  AUTHORS   Warmuth,M., Simon,N., Mitina,O., Mathes,R., Fabbro,D., Manley,P.W.,
            Buchdunger,E., Forster,K., Moarefi,I. and Hallek,M.                
  TITLE     Dual-specific Src and Abl kinase inhibitors, PP1 and CGP76030,     
            inhibit growth and survival of cells expressing imatinib           
            mesylate-resistant Bcr-Abl kinases                                 
  JOURNAL   Blood 101 (2), 664-672 (2003)                                      
   PUBMED   12393636                                                           
  REMARK    GeneRIF: point mutations in Abl that rendered Bcr-Abl imatinib     
            mesylate-resistant, including a mutation that destabilized the     
            inactive conformation of Abl suggesting that the inhibitor required
            inactivation of the kinase prior to binding.                       
REFERENCE   23 (residues 1 to 1148)                                            
  AUTHORS   Donaldson,L.W., Gish,G., Pawson,T., Kay,L.E. and Forman-Kay,J.D.   
  TITLE     Structure of a regulatory complex involving the Abl SH3 domain, the
            Crk SH2 domain, and a Crk-derived phosphopeptide                   
  JOURNAL   Proc. Natl. Acad. Sci. U.S.A. 99 (22), 14053-14058 (2002)          
   PUBMED   12384576                                                           
  REMARK    GeneRIF: determined the NMR solution structure of the ternary      
            complex of the Abl SH3 domain with the Crk SH2 domain bound to a   
            Crk pY221 phosphopeptide                                           
REFERENCE   24 (residues 1 to 1148)                                            
  AUTHORS   Keung,Y.K., Beaty,M., Steward,W., Jackle,B. and Pettnati,M.        
  TITLE     Chronic myelocytic leukemia with eosinophilia, t(9;12)(q34;p13),   
            and ETV6-ABL gene rearrangement: case report and review of the     
            literature                                                         
  JOURNAL   Cancer Genet. Cytogenet. 138 (2), 139-142 (2002)                   
   PUBMED   12505259                                                           
  REMARK    GeneRIF: Chronic myelocytic leukemia with eosinophilia,            
            t(9;12)(q34;p13), and ETV6-ABL gene rearrangement: case report and 
            review of the literature.                                          
REFERENCE   25 (residues 1 to 1148)                                            
  AUTHORS   Pendergast,A.M.                                                    
  TITLE     The Abl family kinases: mechanisms of regulation and signaling     
  JOURNAL   Adv. Cancer Res. 85, 51-100 (2002)                                 
   PUBMED   12374288                                                           
  REMARK    GeneRIF: Review. ABL protein tyrosine kinases regulate cell        
            proliferation, survival, adhesion, migration, stress responses, and
            cytoskeletal dynamics.                                             
REFERENCE   26 (residues 1 to 1148)                                            
  AUTHORS   Bianchi,C., Muradore,I., Corizzato,M., Cornacchini,G., Beretta,L., 
            Erba,E., Del Monte,U. and A  Perego,R.                             
  TITLE     The expression of the non-receptor tyrosine kinases Arg and c-abl  
            is differently modulated in B lymphoid cells at different stages of
            differentiation                                                    
  JOURNAL   FEBS Lett. 527 (1-3), 216-222 (2002)                               
   PUBMED   12220663                                                           
  REMARK    GeneRIF: The data showed that c-abl expression is differently      
            modified in lymphoid B cell lines.                                 
REFERENCE   27 (residues 1 to 1148)                                            
  AUTHORS   Roumiantsev,S., Shah,N.P., Gorre,M.E., Nicoll,J., Brasher,B.B.,    
            Sawyers,C.L. and Van Etten,R.A.                                    
  TITLE     Clinical resistance to the kinase inhibitor STI-571 in chronic     
            myeloid leukemia by mutation of Tyr-253 in the Abl kinase domain   
            P-loop                                                             
  JOURNAL   Proc. Natl. Acad. Sci. U.S.A. 99 (16), 10700-10705 (2002)          
   PUBMED   12149456                                                           
  REMARK    GeneRIF: mutations of Tyr-253 in the nucleotide-binding (P) loop of
            the Abl kinase domain to Phe or His in patients with advanced CML  
            and acquired STI-571 resistance                                    
REFERENCE   28 (residues 1 to 1148)                                            
  AUTHORS   Roche-Lestienne,C., Soenen-Cornu,V., Grardel-Duflos,N., Lai,J.L.,  
            Philippe,N., Facon,T., Fenaux,P. and Preudhomme,C.                 
  TITLE     Several types of mutations of the Abl gene can be found in chronic 
            myeloid leukemia patients resistant to STI571, and they can        
            pre-exist to the onset of treatment                                
  JOURNAL   Blood 100 (3), 1014-1018 (2002)                                    
   PUBMED   12130516                                                           
  REMARK    GeneRIF: Several types of mutations of the Abl gene can be found in
            chronic myeloid leukemia patients resistant to STI571, and they can
            pre-exist to the onset of treatment.                               
REFERENCE   29 (residues 1 to 1148)                                            
  AUTHORS   Wu,B., Zhou,S., Song,L. and Liu,X.                                 
  TITLE     Clinical significance of dual color-dual fusion translocation      
            fluorescence in situ hybridization in the detection of bcr/abl     
            fusion gene                                                        
  JOURNAL   Zhonghua Zhong Liu Za Zhi 24 (4), 364-366 (2002)                   
   PUBMED   12408765                                                           
  REMARK    GeneRIF: expression of bcr/abl hybridized gene in chronic myeloid  
            leukemia (CML), acute lymphatic leukemia (ALL) and polycythemia    
            vera (PV), and its clinical significance                           
REFERENCE   30 (residues 1 to 1148)                                            
  AUTHORS   Era,T.                                                             
  TITLE     Bcr-Abl is a 'molecular switch' for the decision for growth and    
            differentiation in hematopoietic stem cells                        
  JOURNAL   Int. J. Hematol. 76 (1), 35-43 (2002)                              
   PUBMED   12138893                                                           
  REMARK    GeneRIF: This review focuses on how Bcr-Abl affects HSCs and how   
            Bcr-Abl expression alters the properties of HSCs.                  
REFERENCE   31 (residues 1 to 1148)                                            
  AUTHORS   Kim,Y.J., Kim,D.W., Lee,S., Kim,H.J., Kim,Y.L., Hwang,J.Y.,        
            Oh,I.H., Park,Y.H., Lee,Y.K., Min,C.K., Kim,T.G., Han,T.H.,        
            Min,W.S. and Kim,C.C.                                              
  TITLE     Comprehensive comparison of FISH, RT-PCR, and RQ-PCR for monitoring
            the BCR-ABL gene after hematopoietic stem cell transplantation in  
            CML                                                                
  JOURNAL   Eur. J. Haematol. 68 (5), 272-280 (2002)                           
   PUBMED   12144533                                                           
  REMARK    GeneRIF: chronic myelogenous leukemia characterized by             
            translocation between chromosomes 9 and 22 forming a BCR-ABL gene, 
            a specific marker for this disease.                                
REFERENCE   32 (residues 1 to 1148)                                            
  AUTHORS   Zhao,X., Ghaffari,S., Lodish,H., Malashkevich,V.N. and Kim,P.S.    
  TITLE     Structure of the Bcr-Abl oncoprotein oligomerization domain        
  JOURNAL   Nat. Struct. Biol. 9 (2), 117-120 (2002)                           
   PUBMED   11780146                                                           
  REMARK    GeneRIF: crystal structure of the Bcr-Abl oncoprotein              
            oligomerization domain                                             
REFERENCE   33 (residues 1 to 1148)                                            
  AUTHORS   Sanchez-Prieto,R., Sanchez-Arevalo,V.J., Servitja,J.M. and         
            Gutkind,J.S.                                                       
  TITLE     Regulation of p73 by c-Abl through the p38 MAP kinase pathway      
  JOURNAL   Oncogene 21 (6), 974-979 (2002)                                    
   PUBMED   11840343                                                           
  REMARK    GeneRIF: regulates p73 through p38 MAP kinase pathway              
REFERENCE   34 (residues 1 to 1148)                                            
  AUTHORS   Kim,D.W.                                                           
  TITLE     Real time quantitative PCR                                         
  JOURNAL   Exp. Mol. Med. 33 (1 Suppl), 101-109 (2001)                        
   PUBMED   11708318                                                           
  REMARK    GeneRIF: The abl protein was analyzed by real time quantitative    
            PCR.                                                               
REFERENCE   35 (residues 1 to 1148)                                            
  AUTHORS   Gong,J.G., Costanzo,A., Yang,H.Q., Melino,G., Kaelin,W.G. Jr.,     
            Levrero,M. and Wang,J.Y.                                           
  TITLE     The tyrosine kinase c-Abl regulates p73 in apoptotic response to   
            cisplatin-induced DNA damage                                       
  JOURNAL   Nature 399 (6738), 806-809 (1999)                                  
   PUBMED   10391249                                                           
REFERENCE   36 (residues 1 to 1148)                                            
  AUTHORS   Chissoe,S.L., Bodenteich,A., Wang,Y.F., Wang,Y.P., Burian,D.,      
            Clifton,S.W., Crabtree,J., Freeman,A., Iyer,K., Jian,L. et al.     
  TITLE     Sequence and analysis of the human ABL gene, the BCR gene, and     
            regions involved in the Philadelphia chromosomal translocation     
  JOURNAL   Genomics 27 (1), 67-82 (1995)                                      
   PUBMED   7665185                                                            
REFERENCE   37 (residues 1 to 1148)                                            
  AUTHORS   Welch,P.J. and Wang,J.Y.                                           
  TITLE     A C-terminal protein-binding domain in the retinoblastoma protein  
            regulates nuclear c-Abl tyrosine kinase in the cell cycle          
  JOURNAL   Cell 75 (4), 779-790 (1993)                                        
   PUBMED   8242749                                                            
REFERENCE   38 (residues 1 to 1148)                                            
  AUTHORS   Litz,C.E., McClure,J.S., Copenhaver,C.M. and Brunning,R.D.         
  TITLE     Duplication of small segments within the major breakpoint cluster  
            region in chronic myelogenous leukemia                             
  JOURNAL   Blood 81 (6), 1567-1572 (1993)                                     
   PUBMED   8453102                                                            
REFERENCE   39 (residues 1 to 1148)                                            
  AUTHORS   Adams,M.D., Dubnick,M., Kerlavage,A.R., Moreno,R., Kelley,J.M.,    
            Utterback,T.R., Nagle,J.W., Fields,C. and Venter,J.C.              
  TITLE     Sequence identification of 2,375 human brain genes                 
  JOURNAL   Nature 355 (6361), 632-634 (1992)                                  
   PUBMED   1538749                                                            
REFERENCE   40 (residues 1 to 1148)                                            
  AUTHORS   Morris,C.M., Heisterkamp,N., Groffen,J. and Fitzgerald,P.H.        
  TITLE     Entire ABL gene is joined with 5'-BCR in some patients with        
            Philadelphia-positive leukemia                                     
  JOURNAL   Blood 78 (4), 1078-1084 (1991)                                     
   PUBMED   1868241                                                            
REFERENCE   41 (residues 1 to 1148)                                            
  AUTHORS   Szczylik,C., Skorski,T., Nicolaides,N.C., Manzella,L.,             
            Malaguarnera,L., Venturelli,D., Gewirtz,A.M. and Calabretta,B.     
  TITLE     Selective inhibition of leukemia cell proliferation by BCR-ABL     
            antisense oligodeoxynucleotides                                    
  JOURNAL   Science 253 (5019), 562-565 (1991)                                 
   PUBMED   1857987                                                            
REFERENCE   42 (residues 1 to 1148)                                            
  AUTHORS   Soekarman,D., van Denderen,J., Hoefsloot,L., Moret,M., Meeuwsen,T.,
            van Baal,J., Hagemeijer,A. and Grosveld,G.                         
  TITLE     A novel variant of the bcr-abl fusion product in Philadelphia      
            chromosome-positive acute lymphoblastic leukemia                   
  JOURNAL   Leukemia 4 (6), 397-403 (1990)                                     
   PUBMED   2193202                                                            
REFERENCE   43 (residues 1 to 1148)                                            
  AUTHORS   Zhu,Q.S., Heisterkamp,N. and Groffen,J.                            
  TITLE     Characterization of the human ABL promoter regions                 
  JOURNAL   Oncogene 5 (6), 885-891 (1990)                                     
   PUBMED   2163052                                                            
REFERENCE   44 (residues 1 to 1148)                                            
  AUTHORS   Fainstein,E., Einat,M., Gokkel,E., Marcelle,C., Croce,C.M.,        
            Gale,R.P. and Canaani,E.                                           
  TITLE     Nucleotide sequence analysis of human abl and bcr-abl cDNAs        
  JOURNAL   Oncogene 4 (12), 1477-1481 (1989)                                  
   PUBMED   2687768                                                            
REFERENCE   45 (residues 1 to 1148)                                            
  AUTHORS   Chen,S.J., Chen,Z., Font,M.P., d'Auriol,L., Larsen,C.J. and        
            Berger,R.                                                          
  TITLE     Structural alterations of the BCR and ABL genes in Ph1 positive    
            acute leukemias with rearrangements in the BCR gene first intron:  
            further evidence implicating Alu sequences in the chromosome       
            translocation                                                      
  JOURNAL   Nucleic Acids Res. 17 (19), 7631-7642 (1989)                       
   PUBMED   2678002                                                            
REFERENCE   46 (residues 1 to 1148)                                            
  AUTHORS   Fainstein,E., Marcelle,C., Rosner,A., Canaani,E., Gale,R.P.,       
            Dreazen,O., Smith,S.D. and Croce,C.M.                              
  TITLE     A new fused transcript in Philadelphia chromosome positive acute   
            lymphocytic leukaemia                                              
  JOURNAL   Nature 330 (6146), 386-388 (1987)                                  
   PUBMED   2825022                                                            
REFERENCE   47 (residues 1 to 1148)                                            
  AUTHORS   Bernards,A., Rubin,C.M., Westbrook,C.A., Paskind,M. and            
            Baltimore,D.                                                       
  TITLE     The first intron in the human c-abl gene is at least 200 kilobases 
            long and is a target for translocations in chronic myelogenous     
            leukemia                                                           
  JOURNAL   Mol. Cell. Biol. 7 (9), 3231-3236 (1987)                           
   PUBMED   3313010                                                            
REFERENCE   48 (residues 1 to 1148)                                            
  AUTHORS   Shtivelman,E., Lifshitz,B., Gale,R.P., Roe,B.A. and Canaani,E.     
  TITLE     Alternative splicing of RNAs transcribed from the human abl gene   
            and from the bcr-abl fused gene                                    
  JOURNAL   Cell 47 (2), 277-284 (1986)                                        
   PUBMED   3021337                                                            
REFERENCE   49 (residues 1 to 1148)                                            
  AUTHORS   Grosveld,G., Verwoerd,T., van Agthoven,T., de Klein,A.,            
            Ramachandran,K.L., Heisterkamp,N., Stam,K. and Groffen,J.          
  TITLE     The chronic myelocytic cell line K562 contains a breakpoint in bcr 
            and produces a chimeric bcr/c-abl transcript                       
  JOURNAL   Mol. Cell. Biol. 6 (2), 607-616 (1986)                             
   PUBMED   3023859                                                            
REFERENCE   50 (residues 1 to 1148)                                            
  AUTHORS   Heisterkamp,N., Stam,K., Groffen,J., de Klein,A. and Grosveld,G.   
  TITLE     Structural organization of the bcr gene and its role in the Ph'    
            translocation                                                      
  JOURNAL   Nature 315 (6022), 758-761 (1985)                                  
   PUBMED   2989703                                                            
REFERENCE   51 (residues 1 to 1148)                                            
  AUTHORS   Shtivelman,E., Lifshitz,B., Gale,R.P. and Canaani,E.               
  TITLE     Fused transcript of abl and bcr genes in chronic myelogenous       
            leukaemia                                                          
  JOURNAL   Nature 315 (6020), 550-554 (1985)                                  
   PUBMED   2989692                                                            
REFERENCE   52 (residues 1 to 1148)                                            
  AUTHORS   Groffen,J., Stephenson,J.R., Heisterkamp,N., de Klein,A.,          
            Bartram,C.R. and Grosveld,G.                                       
  TITLE     Philadelphia chromosomal breakpoints are clustered within a limited
            region, bcr, on chromosome 22                                      
  JOURNAL   Cell 36 (1), 93-99 (1984)                                          
   PUBMED   6319012                                                            
REFERENCE   53 (residues 1 to 1148)                                            
  AUTHORS   Heisterkamp,N., Stephenson,J.R., Groffen,J., Hansen,P.F., de       
            Klein,A., Bartram,C.R. and Grosveld,G.                             
  TITLE     Localization of the c-ab1 oncogene adjacent to a translocation     
            break point in chronic myelocytic leukaemia                        
  JOURNAL   Nature 306 (5940), 239-242 (1983)                                  
   PUBMED   6316147                                                            
REFERENCE   54 (residues 1 to 1148)                                            
  AUTHORS   Heisterkamp,N., Groffen,J. and Stephenson,J.R.                     
  TITLE     The human v-abl cellular homologue                                 
  JOURNAL   J. Mol. Appl. Genet. 2 (1), 57-68 (1983)                           
   PUBMED   6302194                                                            
REFERENCE   55 (residues 1 to 1148)                                            
  AUTHORS   Groffen,J., Heisterkamp,N., Reynolds,F.H. Jr. and Stephenson,J.R.  
  TITLE     Homology between phosphotyrosine acceptor site of human c-abl and  
            viral oncogene products                                            
  JOURNAL   Nature 304 (5922), 167-169 (1983)                                  
   PUBMED   6191223                                                            
REFERENCE   56 (residues 1 to 1148)                                            
  AUTHORS   Groffen,J., Heisterkamp,N., Grosveld,F., Van de Ven,W. and         
            Stephenson,J.R.                                                    
  TITLE     Isolation of human oncogene sequences (v-fes homolog) from a cosmid
            library                                                            
  JOURNAL   Science 216 (4550), 1136-1138 (1982)                               
   PUBMED   6281890                                                            
REFERENCE   57 (residues 1 to 1148)                                            
  AUTHORS   Mount,S.M.                                                         
  TITLE     A catalogue of splice junction sequences                           
  JOURNAL   Nucleic Acids Res. 10 (2), 459-472 (1982)                          
   PUBMED   7063411                                                            
COMMENT     REVIEWED REFSEQ: This record has been curated by NCBI staff. The   
            reference sequence was derived from M14752.1, M14753.1 and         
            X16416.1.                                                          
                                                                               
            Summary:  The ABL1 protooncogene encodes a cytoplasmic and nuclear 
            protein tyrosine kinase that has been implicated in processes of   
            cell differentiation, cell division, cell adhesion, and stress     
            response.  Activity of c-Abl protein is negatively regulated by its
            SH3 domain, and deletion of the SH3 domain turns ABL1 into an      
            oncogene.  The t(9;22) translocation results in the head-to-tail   
            fusion of the BCR (MIM:151410) and ABL1 genes present in many cases
            of chronic myelogeneous leukemia.  The DNA-binding activity of the 
            ubiquitously expressed ABL1 tyrosine kinase is regulated by        
            CDC2-mediated phosphorylation, suggesting a cell cycle function for
            ABL1.  The ABL1 gene is expressed as either a 6- or 7-kb mRNA      
            transcript, with alternatively spliced first exons spliced to the  
            common exons 2-11.                                                 
                                                                               
            Transcript Variant:  Transcript variant b includes exon 1b, but not
            exon 1a, resulting in a different N-terminus. This variant contains
            an N-terminal glycine which could be myristylated and is thus      
            postulated to be directed to the plasma membrane.                  
FEATURES             Location/Qualifiers                                       
     source          1..1148                                                   
                     /organism="Homo sapiens"                                  
                     /db_xref="taxon:9606"                                     
                     /chromosome="9"                                           
                     /map="9q34.1"                                             
     Protein         1..1148                                                   
                     /product="v-abl Abelson murine leukemia viral oncogene    
                     homolog 1 isoform b"                                      
                     /EC_number="2.7.1.112"                                    
                     /note="Abelson murine leukemia viral (v-abl) oncogene     
                     homolog 1; proto-oncogene tyrosine-protein kinase ABL1"   
     Region          42..1148                                                  
                     /region_name="Protein tyrosine kinase [Signal transduction
                     mechanisms]"                                              
                     /note="KOG4278"                                           
                     /db_xref="CDD:22054"                                      
     Region          83..137                                                   
                     /region_name="SH3 domain"                                 
                     /note="SH3"                                               
                     /db_xref="CDD:22871"                                      
     Region          145..234                                                  
                     /region_name="Src homology 2 domains"                     
                     /note="SH2"                                               
                     /db_xref="CDD:16538"                                      
     Region          252..514                                                  
                     /region_name="Tyrosine kinase, catalytic domain"          
                     /note="TyrKc"                                             
                     /db_xref="CDD:5392"                                       
     CDS             1..1148                                                   
                     /gene="ABL1"                                              
                     /coded_by="NM_007313.1:1..3447"                           
                     /note="isoform b is encoded by transcript variant b;      
                     go_component: nucleus [goid 0005634] [evidence NR];       
                     go_function: protein-tyrosine kinase activity [goid       
                     0004713] [evidence TAS] [pmid 10391249];                  
                     go_function: DNA binding [goid 0003677] [evidence NR];    
                     go_function: ATP binding [goid 0005524] [evidence IEA];   
                     go_function: transferase activity [goid 0016740] [evidence
                     IEA];                                                     
                     go_process: S-specific transcription in mitotic cell cycle
                     [goid 0000115] [evidence TAS] [pmid 8242749];             
                     go_process: DNA damage response, signal transduction      
                     resulting in induction of apoptosis [goid 0008630]        
                     [evidence TAS] [pmid 10391249];                           
                     go_process: mismatch repair [goid 0006298] [evidence TAS] 
                     [pmid 10391249];                                          
                     go_process: regulation of transcription, DNA-dependent    
                     [goid 0006355] [evidence TAS] [pmid 8242749];             
                     go_process: oncogenesis [goid 0007048] [evidence TAS]     
                     [pmid 2825022];                                           
                     go_process: regulation of cell cycle [goid 0000074]       
                     [evidence TAS] [pmid 8242749];                            
                     go_process: protein modification [goid 0006464] [evidence 
                     NR];                                                      
                     go_process: cell growth and/or maintenance [goid 0008151] 
                     [evidence IEA];                                           
                     go_process: protein amino acid phosphorylation [goid      
                     0006468] [evidence IEA];                                  
                     go_process: intracellular signaling cascade [goid 0007242]
                     [evidence IEA]"                                           
                     /db_xref="GeneID:25"                                      
                     /db_xref="LocusID:25"                                     
                     /db_xref="MIM:189980"                                     
ORIGIN                                                                         
        1 mgqqpgkvlg dqrrpslpal hfikgagkke ssrhggphcn vfveqalqrp vasdfepqgl    
       61 seaarwnske nllagpsend pnlfvalydf vasgdntlsi tkgeklrvlg ynhngewcea    
      121 qtkngqgwvp snyitpvnsl ekhswyhgpv srnaaeypls sgingsflvr esesspsqrs    
      181 islryegrvy hyrintasdg klyvssesrf ntlaelvhhh stvadglitt lhypapkrnk    
      241 ptvygvspny dkwemertdi tmkhklgggq ygevyegvwk kysltvavkt lkedtmevee    
      301 flkeaavmke ikhpnlvqll gvctreppfy iitefmtygn lldylrecnr qevnavvlly    
      361 matqissame ylekknfihr dlaarnclvg enhlvkvadf glsrlmtgdt ytahagakfp    
      421 ikwtapesla ynkfsiksdv wafgvllwei atygmspypg idrsqvyell ekdyrmkrpe    
      481 gcpekvyelm racwqwnpsd rpsfaeihqa fetmfqessi sdevekelgk qgvrgavttl    
      541 lqapelptkt rtsrraaehr dttdvpemph skgqgesdpl dhepavspll prkergppeg    
      601 glnederllp kdkktnlfsa likkkkktap tppkrsssfr emdgqperrg ageeegrdis    
      661 ngalaftpld tadpakspkp sngagvpnga lresggsgfr sphlwkksst ltssrlatge    
      721 eegggssskr flrscsvscv phgakdtewr svtlprdlqs tgrqfdsstf gghksekpal    
      781 prkragenrs dqvtrgtvtp pprlvkknee aadevfkdim esspgssppn ltpkplrrqv    
      841 tvapasglph keeawkgsal gtpaaaepvt ptskagsgap rgtskgpaee srvrrhkhss    
      901 espgrdkgkl sklkpapppp paasagkagg kpsqrpgqea ageavlgakt katslvdavn    
      961 sdaakpsqpa eglkkpvlpa tpkphpakps gtpispapvp lstlpsassa lagdqpssta    
     1021 fiplistrvs lrktrqpper asgaitkgvv ldstealcla isgnseqmas hsavleagkn    
     1081 lytfcvsyvd siqqmrnkfa freainklen nlrelqicpa sagsgpaatq dfskllssvk    
     1141 eisdivqr                                                             
//                                                                             
                                                                               